At AACC booth 3135, Thermo Fisher Scientific, Waltham, Mass, showcased the fully automated Thermo Scientific Phadia 2500E laboratory system for allergy and autoimmune testing.
Analyzing up to 25,000 samples per week, the system detects and quantifies relevant antibodies in blood samples to identify possible allergy or autoimmune sensitivity. The company’s portfolio of allergy test kits has been expanded to include ImmunoCAP allergen components for hazelnut, walnut, and cashews, to identify patients who may have potentially serious reactions to a wider variety of food products.
The company also introduced Mas Liquimmune multianalyte controls, which according to the company are the first quality control standards for clinical chemistry with a shelf life of 5 years. A longer shelf life for control analytes reduces potentially costly laboratory downtime experienced when having to validate new lots due to expiration.
Also on display was the Prelude LX-4 MD high-performance liquid chromatography system, listed with FDA as a Class I medical device for in vitro diagnostic applications. The device features four parallel channels, which can deliver up to four different separations to a single mass spectrometer with identical or different methods to enhance sample throughput.
“As healthcare systems face the issue of improving patient care while reducing costs, the clinical laboratory becomes increasingly important in aiding diagnosis and treatment,” says Marc N. Casper, president and chief executive of Thermo Fisher Scientific. “Our role is to provide the tools to help our customers achieve rapid and more-accurate results, while increasing laboratory productivity.”
For more information, visit Thermo Fisher Scientific.
